2019

Nemera News

  • World Glaucoma week 2018!

    March 11, 2019

    World Glaucoma week 2019! This week we are celebrating the World Glaucoma Week. Initiative born by the collaboration between the World Glaucoma Association and the World Glaucoma Patient Association. The objective is to bring awareness to the importance of regular eye checks to detect glaucoma in its early stages. What is the glaucoma? Glaucoma is an eye diseases that is

    Read more
  • Press Release : Our preservative-free multidose eye dropper Novelia® approved for Santen’s Cosopt®

    March 5, 2019

    Nemera’s preservative-free multidose eye dropper Novelia® approved for Santen’s Cosopt® for Glaucoma treatments.   Santen announced that the preservative-free formulation Cosopt iMulti® will launch in 29 European countries in the coming months.   Nemera’s multidose eye dropper Novelia® has been approved for the preservative-free formulation Cosopt iMulti® There is an innovation in glaucoma management by providing preservative-free medicines in multi-dose

    Read more
  • Seen in the press: Nemera’s article featured in the latest ‘Pharmacy & Packaging’ chinese magazine

    February 20, 2019

    ‘Pharmacy & Packaging’ magazine features Nemera’s article about the development path to bioequivalence for a nasal spray.   The last issue of ‘Pharmacy & Packaging’ magazine, the China National Pharmaceutical Packaging Association’s publication, includes an article from Nemera:  “The Development Path to Bioequivalence for a Nasal Spray”.     In this article, Nemera’s experts Pascale Farjas (Global Category Manager ENT), Alain Regard (Technology Product

    Read more
  • Seen in the press: Nemera’s article featured in February ‘European Pharmaceutical Manufacturer’

    February 19, 2019

    European Pharmaceutical Manufacturer magazine features Nemera’s article ‘Taking the Advanced approach’ about patient adherence for nasal spray.   The recently published European Pharmaceutical Manufacturer magazine includes the article from Nemera ‘Taking the Advanced approach’, presenting how a nasal spray improve patients’ adherence. In this article, Pascale Farjas, Global Category Manager at Nemera, examines the design features that help improve adherence for patients using

    Read more
  • Come to meet us at Pharmapack on February 6th and 7th!

    January 24, 2019

    Come to meet us at Pharmapack on February 6th and 7th!   Pharmapack will take place in Paris, on February 6-7. You can meet us at our booth C62, to meet our team and discover our latest innovative drug delivery devices: Novelia®: our multidose eyedropper for preservative-free formulations. With Novelia®, 0% preservatives, 100% eye protection! Safe’n’Sound®: our platform of fully

    Read more
  • Two new market references recently added to Safe’n’Sound®, our passive safety device platform

    January 23, 2019

    Two new market references recently added to Safe’n’Sound®, our passive safety device platform Safe’n’Sound ® is on the market in Europe and in the US with two newly registered injectable medications. These formulations have received market authorizations in pre-filled syringes with Nemera Safe’n’Sound add-on safety device, in both 1ml and 2.25ml presentations.   In the parenteral industry, needlestick injuries are

    Read more
  • NEMERA will attend SMI Pre-Filled Syringes & Injectable Drug Devices on January 16th and 17th!

    January 15, 2019

    NEMERA will attend SMI Pre-Filled Syringes & Injectable Drug Devices on January 16th and 17th! ‘SMI Pre-Filled Syringes & Injectable Drug Devices’ will take place in London, on January 16-17. This conference gives a comprehensive review within the field of injectable drug devices while reviewing interesting new technologies and innovations of injectable delivery devices. SMI is based on the impact

    Read more
  • Seen in the press: Nemera’s article featured in January ‘Ophthalmic Drug delivery’

    January 14, 2019

    “Ophthalmic Drug Delivery” magazine features Nemera’s article about the importance of user studies to understand what patients need.   The recently published “Ophthalmic Drug Delivery” magazine includes an article from Nemera:  “User testing: critical for truly understanding patient needs”. In this article, Fanny Sellier, Global Category Manager, Ophthalmic Products, Nemera, presents three comparative user studies between Nemera’s Novelia® preservative-free, multidose eyedropper and similar

    Read more
  • Press Release : Our innovation center celebrates 100 employees!

    January 9, 2019

    Our innovation center reaches an important milestone of 100 employees   Nemera’s Innovation Center just hired its 100th employee.   The Innovation Center, a multi-discipline drug delivery device development expertise center, was created in 2008. Early on, it included a few engineers, who worked on internal device development. Over the last 10 years, it has grown consistently to reach 100

    Read more